Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO 2018) with one intermediate-risk factor: a multicentre retrospective cohort study of 63,926 cases
Postoperative adjuvant chemotherapy or chemoradiotherapy did not significantly improve the outcomes of FIGO 2018 IA-IIA cervical adenocarcinoma patients with only one intermediate risk factor.
Authors
- Chunlin Chen (ORCID: https://orcid.org/0000-0002-7140-5668)
- Lixin Sun (ORCID: https://orcid.org/0000-0001-8203-0841)
- Jinghe Lang
- Ping Liu (ORCID: https://orcid.org/0000-0003-3374-886X)
- Zhumei Cui (ORCID: https://orcid.org/0000-0003-1824-0646)
- Hongwei Zhao (ORCID: https://orcid.org/0000-0001-6409-5537)
- Cong Liang (ORCID: https://orcid.org/0000-0002-5572-5354)
- Jiaxin Fu (ORCID: https://orcid.org/0009-0009-9337-1452)
Institutions
- Qingdao University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Shanxi Provincial Cancer Hospital (CN)
- Nanfang Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1186/s12957-025-03739-9
- Citations
- 2
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.11